AFM-T
| Company | Aristopharma Limited | |
|---|---|---|
| Active Ingredient |  Fluorometholone 0.1% + Tetrahydrozoline Hydrochloride 0.025% Eye prep | |
| Variants |
| |
Dose
Adults and children (above 2 years of age):
Instill 1-2 drops into conjunctivalsac 2-3 times daily. Dose may be increased to 1 drop hourly during first 24-48 hr.
Alternative Brands to AFM-T
Indication
Keratitis, Allergic and inflammatory conditions of the eye, Iridocyclitis, Iritis, Acute & chronic conjunctivitis, Scleritis, Episcleritis, Myositis. Post-op conditions after strabotomy, Cataract & glaucoma operations
Contra Indication
This medication is contraindicated in following cases-
• Viral infection of cornea & conjunctiva caused by Herpes simplex etc
• Fungal infection of the cornea & conjunctiva
• Tuberculous infections
• Ulcerous processes of the cornea
• Hypersensitivity to any ingredients of this formulation.
Side Effect
Mild burning sensation, reversible increase in intra ocular pressure (IOP), reactive hyperemia/rebound effect, cataract & corneal defects, glaucoma, systemic effects (chronic use).
Therapeutic Classes
- Ophthalmic Steroid preparations
Indicaitons
- Conjunctivitis
- Keratitis
- Allergic and inflammatory conditions of the eye
- Iridocyclitis
- Iritis
- Ocular inflammation
- Acute & chronic conjunctivitis
- Scleritis
- Episcleritis
- Myositis. Post-op conditions after strabotomy
- Cataract & glaucoma operations
- Eye allergy
Precaution
• Prolonged use in pregnant women and infants should be avoided
• This medication should be used with caution in patients under treatment with MAO inhibitors
• Do not apply while wearing soft contact lenses. The lenses should be removed before application of the drops and not reinserted earlier than 15 minutes after use.
• Shake well before use.
Mode of Action
Fluorometholone suppresses the migration of polymorphonuclear leukocytes and reversal of increased capillary permeability thus decreasing inflammation.
May stimulate alpha-adrenergic receptors in the arterioles of the conjunctiva; produces vasoconstriction. May produce mydriasis when applied to the conjunctiva, but this effect is usually minimal with the concentrations used as ocular decongestants.